Transformation of a MGUS to Overt Multiple Myeloma: The Possible Role of a Pituitary Macroadenoma Secreting High Levels of Insulin-like Growth Factor 1 (IGF-1)
暂无分享,去创建一个
[1] S. Melmed. Acromegaly and cancer: not a problem? , 2001, The Journal of clinical endocrinology and metabolism.
[2] B. Klein,et al. Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway. , 2000 .
[3] S. Rudikoff,et al. Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. , 2000, Blood.
[4] S. Burdach,et al. The insulin-like growth factor system in normal and malignant hematopoietic cells. , 1999, Blood.
[5] M. Donath,et al. Insulin-Like Growth Factor I , 1999, Drugs & aging.
[6] P. Georgii‐Hemming,et al. Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines. , 1996, Blood.
[7] G. Freund,et al. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines. , 1994, Cancer research.
[8] H. Kimata,et al. Differential effect of growth hormone and insulin-like growth factor-I, insulin-like growth factor-II, and insulin on Ig production and growth in human plasma cells. , 1994, Blood.
[9] R. Clark,et al. Insulin-like growth factor-1 stimulation of lymphopoiesis. , 1993, The Journal of clinical investigation.
[10] K. Asplund,et al. Acromegaly and multiple myeloma. , 1988, Annals of internal medicine.